Cargando…

A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies

BACKGROUND: In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable method yielding highly concentrated and pure platelet samples is usually not available for immunological studies. Plateletpheresis is widely used in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pablo‐Torres, Carmela, Delgado‐Dolset, María Isabel, Sanchez‐Solares, Javier, Mera‐Berriatua, Leticia, Núñez Martín Buitrago, Lucía, Reaño Martos, Mar, Bueno, José Luis, Escribese, Maria M., Barber, Domingo, Gomez‐Casado, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796013/
https://www.ncbi.nlm.nih.gov/pubmed/35757844
http://dx.doi.org/10.1111/cea.14192
_version_ 1784860385828929536
author Pablo‐Torres, Carmela
Delgado‐Dolset, María Isabel
Sanchez‐Solares, Javier
Mera‐Berriatua, Leticia
Núñez Martín Buitrago, Lucía
Reaño Martos, Mar
Bueno, José Luis
Escribese, Maria M.
Barber, Domingo
Gomez‐Casado, Cristina
author_facet Pablo‐Torres, Carmela
Delgado‐Dolset, María Isabel
Sanchez‐Solares, Javier
Mera‐Berriatua, Leticia
Núñez Martín Buitrago, Lucía
Reaño Martos, Mar
Bueno, José Luis
Escribese, Maria M.
Barber, Domingo
Gomez‐Casado, Cristina
author_sort Pablo‐Torres, Carmela
collection PubMed
description BACKGROUND: In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable method yielding highly concentrated and pure platelet samples is usually not available for immunological studies. Plateletpheresis is widely used in the clinics for donation purposes. In this study, we designed a protocol based on plateletpheresis to obtain Platelet‐Rich Plasma (PRP), Platelet‐Poor Plasma (PPP) as well as CD3(+) and CD14(+) cells matched samples from a waste plateletpheresis product for immunological studies. METHODS: Twenty‐seven subjects were voluntarily subjected to plateletpheresis. PRP, PPP and blood cell concentrate contained in a leukocyte reduction system chamber (LRSC) were obtained in this process. CD3(+) and CD14(+) cells were isolated from the LRSC by density‐gradient centrifugation and positive magnetic bead isolation. RNA was isolated from PRP, CD3(+) and CD14(+) cell samples and used for transcriptomic studies by Affymetrix. PRP and PPP samples were used for platelet protein quantification by multiplex assays. RESULTS: A reliable high yield method to obtain matched samples of PRP, PPP, CD3(+) and CD14(+) from a single donor for RNA and protein analyses has been designed. The RNA quality indicators (RQI) routinely used for other cell types were not suitable for platelet RNA characterization. Despite this, the platelet RNA was valid for transcriptomic studies by Affymetrix, as platelet transcripts obtained in our previous studies were confirmed in PRP samples. Platelet samples were enriched in platelet factors as determined in protein multiplex analysis. CONCLUSIONS: We have developed a method that yields not only high content and pure platelet samples from a single donor but also CD3(+) and CD14(+) matched samples that can be used for RNA and protein analyses in immunological studies.
format Online
Article
Text
id pubmed-9796013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97960132022-12-28 A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies Pablo‐Torres, Carmela Delgado‐Dolset, María Isabel Sanchez‐Solares, Javier Mera‐Berriatua, Leticia Núñez Martín Buitrago, Lucía Reaño Martos, Mar Bueno, José Luis Escribese, Maria M. Barber, Domingo Gomez‐Casado, Cristina Clin Exp Allergy Original Articles BACKGROUND: In previous studies with peripheral blood cells, platelet factors were found to be associated with severe allergic phenotypes. A reliable method yielding highly concentrated and pure platelet samples is usually not available for immunological studies. Plateletpheresis is widely used in the clinics for donation purposes. In this study, we designed a protocol based on plateletpheresis to obtain Platelet‐Rich Plasma (PRP), Platelet‐Poor Plasma (PPP) as well as CD3(+) and CD14(+) cells matched samples from a waste plateletpheresis product for immunological studies. METHODS: Twenty‐seven subjects were voluntarily subjected to plateletpheresis. PRP, PPP and blood cell concentrate contained in a leukocyte reduction system chamber (LRSC) were obtained in this process. CD3(+) and CD14(+) cells were isolated from the LRSC by density‐gradient centrifugation and positive magnetic bead isolation. RNA was isolated from PRP, CD3(+) and CD14(+) cell samples and used for transcriptomic studies by Affymetrix. PRP and PPP samples were used for platelet protein quantification by multiplex assays. RESULTS: A reliable high yield method to obtain matched samples of PRP, PPP, CD3(+) and CD14(+) from a single donor for RNA and protein analyses has been designed. The RNA quality indicators (RQI) routinely used for other cell types were not suitable for platelet RNA characterization. Despite this, the platelet RNA was valid for transcriptomic studies by Affymetrix, as platelet transcripts obtained in our previous studies were confirmed in PRP samples. Platelet samples were enriched in platelet factors as determined in protein multiplex analysis. CONCLUSIONS: We have developed a method that yields not only high content and pure platelet samples from a single donor but also CD3(+) and CD14(+) matched samples that can be used for RNA and protein analyses in immunological studies. John Wiley and Sons Inc. 2022-07-16 2022-10 /pmc/articles/PMC9796013/ /pubmed/35757844 http://dx.doi.org/10.1111/cea.14192 Text en © 2022 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Pablo‐Torres, Carmela
Delgado‐Dolset, María Isabel
Sanchez‐Solares, Javier
Mera‐Berriatua, Leticia
Núñez Martín Buitrago, Lucía
Reaño Martos, Mar
Bueno, José Luis
Escribese, Maria M.
Barber, Domingo
Gomez‐Casado, Cristina
A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
title A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
title_full A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
title_fullStr A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
title_full_unstemmed A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
title_short A method based on plateletpheresis to obtain functional platelet, CD3 (+) and CD14 (+) matched populations for research immunological studies
title_sort method based on plateletpheresis to obtain functional platelet, cd3 (+) and cd14 (+) matched populations for research immunological studies
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796013/
https://www.ncbi.nlm.nih.gov/pubmed/35757844
http://dx.doi.org/10.1111/cea.14192
work_keys_str_mv AT pablotorrescarmela amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT delgadodolsetmariaisabel amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT sanchezsolaresjavier amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT meraberriatualeticia amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT nunezmartinbuitragolucia amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT reanomartosmar amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT buenojoseluis amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT escribesemariam amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT barberdomingo amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT gomezcasadocristina amethodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT pablotorrescarmela methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT delgadodolsetmariaisabel methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT sanchezsolaresjavier methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT meraberriatualeticia methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT nunezmartinbuitragolucia methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT reanomartosmar methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT buenojoseluis methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT escribesemariam methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT barberdomingo methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies
AT gomezcasadocristina methodbasedonplateletpheresistoobtainfunctionalplateletcd3andcd14matchedpopulationsforresearchimmunologicalstudies